MAY 09, 2018 11:16 AM PDT

Machine Learning Builds a Database of Obesity Variants

WRITTEN BY: Carmen Leitch

A new partnership has been created between the genomics data search company Genomenon and Rhythm Pharmaceuticals, which aims to create and manufacture therapies that can treat rare disorders that cause obesity. The team has aimed to establish a database that compiles genetic mutations that have been linked, by published research studies, with the development of obesity. The hope is that drug development can be accelerated with this new tool.

DNA (green) residing in fluid outside of cells' main nuclei. / Credit: Wenjing Wu/Memorial Sloan Kettering Cancer Center/Nature

Genomenon has utilized the Mastermind Genomic Search Engine so that genes and variants that have been associated with obesity are easily searchable. An evidence-based method will be employed to ensure the integrity of the findings; only clinically relevant genes and variants, as well as the studies that identified them, will be included. Rhythm can then learn more about how genetic factors influence obesity, and how they might be manipulated to combat it. 

"We are combining computational variant analysis and population studies with the published scientific evidence identified and collated by Genomenon to create a knowledge base on the molecular genetics related to obesity,” said Lex Van der Ploeg, Chief Scientific Officer of Rhythm. "The evidence provided by Genomenon’s advanced machine learning tools and genomic search database may help identify patients who might be appropriate for treatment with therapies specifically targeted towards genetic pathways that contribute to obesity.”

Mastermind will be the first genomic search engine that combines genetic data with evidence obtained in the laboratory and reported in peer-reviewed literature. Genomenon used machine learning and Genomic Language Processing that can sift through articles to find relevant information; the bioinformaticians harvested information about mutations that cause disease from millions of research articles. A team of scientists at Genomenon then reviewed the work.

The result was a database of biomarkers, including over 10,000 mutations from 120 genes that have been connected with obesity. It took less than 60 days to compile the information, which includes the citations for every one of the mutations. Machine learning was thus able to quickly complete a task that takes a person about a year to do.

“This is an exciting demonstration on how genomic language processing and machine learning can drive important advances in drug development,” said Mike Klein, CEO of Genomenon. “We’re thrilled to be working with Rhythm Pharmaceuticals and look forward to our ongoing work together.”

You can find out more about how to use Mastermind from the video, produced by Genomenon.

Source: Genomenon

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 07, 2022
Cell & Molecular Biology
Sequencing Living Cells, Individually, Without Killing Them
SEP 07, 2022
Sequencing Living Cells, Individually, Without Killing Them
When genes in a cell are active, they are transcribed into messenger RNA (mRNA) molecules. So researchers can take a sna ...
SEP 28, 2022
Microbiology
Humans and Our Gut Microbes Evolved Together
SEP 28, 2022
Humans and Our Gut Microbes Evolved Together
We each carry thousands of different species of microorganisms in our gastrointestinal tracts, and that gut microbiome h ...
OCT 16, 2022
Genetics & Genomics
Gene Clusters Influence Mice Longevity
OCT 16, 2022
Gene Clusters Influence Mice Longevity
In a recent study published in Science, an international team of researchers led by the Swiss Federal Institute of Techn ...
NOV 02, 2022
Clinical & Molecular DX
New Genetic Variants Identified as Risk Factors for Ovarian Cancer
NOV 02, 2022
New Genetic Variants Identified as Risk Factors for Ovarian Cancer
Ovarian cancer is a complex disease resulting from mutated cells in the ovaries. As the cells multiply, they can invade ...
NOV 09, 2022
Genetics & Genomics
What happened to the Neandertals?
NOV 09, 2022
What happened to the Neandertals?
New research suggests that interbreeding, not violence, may have caused the Neandertal extinction.
NOV 16, 2022
Coronavirus
Divergent SARS-CoV-2 Variant Reveals Evidence of Deer-to-Human Transmission
NOV 16, 2022
Divergent SARS-CoV-2 Variant Reveals Evidence of Deer-to-Human Transmission
After only a few months of the COVID-19 pandemic, researchers had identified the virus that causes the disease, SARS-CoV ...
Loading Comments...